Homepage

Record

RefNoRR/14/18
LevelItem
TitleLetter from Edward Albert Sharpey-Schafer, to Richard Tetley Glazebrook, regarding a paper 'The pharmacology of aconitine, diacetyl-aconitine, benzaconine, and aconine, considered in relation to their chemical constitution' by John Theodore Cash and Wyndham Rowland Dunstan
Date18 January 1898
DescriptionMichael Foster thinks the paper should be considered by both the Physicochemical and the Physiological Committees. Asks if he can suggest a chemist to referee the paper. There is a chemical element to the paper, but the bulk is physiological.

Subject: Physics and Chemistry

[Published in the Philosophical Transactions of the Royal Society]
Extent2p
FormatManuscript
PhysicalDescriptionLetter on paper
Digital imagesView item on Science in the Making
AccessStatusOpen
RelatedMaterialDOI: 10.1098/rstb.1898.0004 Vol.190 1898
RelatedRecordRR/14/19
RR/14/20
RR/14/21
Add to My Items
    Classified Papers

    Classified Papers

    Useful Links

    Collection highlights

    Browse the records of some of our collections, which cover all branches of science and date from the 12th century onwards. These include the published works of Fellows of the Royal Society, personal papers of eminent scientists, letters and manuscripts sent to the Society or presented at meetings, and administrative records documenting the Society's activities since our foundation in 1660.

    Papers of Robert Boyle
    Papers of Robert Boyle
    Early Letters
    Early Letters
    Classified Papers
    Classified Papers
    Papers of Colin Pillinger
    Papers of Colin Pillinger
    Browse Collections

    The Royal Society

    The Royal Society is a Fellowship of many of
    the world's most eminent scientists and is the
    oldest scientific academy in continuous existence.
    Registered charity number 207043

    Website design ©CalmView



    CONTACT US

    + 44 207 451 2500
    (Lines open Mon-Fri, 9:00-17:00. Excludes bank holidays)

    6-9 Carlton House Terrace, London SW1Y 5AG

    Email Us →

    SUBSCRIBE

    Subscribe to our newsletters to be updated with the
    latest news on innovation, events, articles and reports.

    Subscribe →

    © CalmView